mdx Mice Manifest More Severe Muscle Dysfunction and Diaphragm Force Deficits than Do mdx Mice
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast to the mdx/bl10 and mdx/bl6 models, their muscle pathology and functioning are slightly more impaired, likely owing to the absence of revertant muscle fibres (Box 1) (Danko et al., 1992; Beastrom et al., 2011).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Beastrom et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dystrophin: the protein product of the Duchenne muscular dystrophy locus
Hoffman, E. P., Brown, R. H., & Kunkel, L. M. (1987) · Cell · doi:10.1016/0092-8674(87)90579-4 · Cited by 4,693
X chromosome-linked muscular dystrophy (mdx) in the mouse
Bulfield, G., Siller, W. G., Wight, P. A., & Moore, K. J. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.4.1189 · Cited by 1,765
Short Telomeres and Stem Cell Exhaustion Model Duchenne Muscular Dystrophy in mdx/mTR Mice
Sacco, A., Mourkioti, F., Tran, R., Choi, J., Llewellyn, M., Kraft, P., Shkreli, M., Delp, S., Pomerantz, J. H., Artandi, S. E., et al. (2010) · Cell · doi:10.1016/j.cell.2010.11.039 · Cited by 512
Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
Straub, V., Rafael, J. A., Chamberlain, J. S., & Campbell, K. P. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.2.375 · Cited by 488
Liu, M., Yue, Y., Harper, S. Q., Grange, R. W., Chamberlain, J. S., & Duan, D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.09.013 · Cited by 178
Research works printed but not linked: 63
- Monaco, 1986, Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene, Nature, 323, 646, 10.1038/323646a0 · DOI · Paper page
- Matsumura, 1993, The role of the dystrophin-glycoprotein complex in the molecular pathogenesis of muscular dystrophies, Neuromuscul Disord, 3, 533, 10.1016/0960-8966(93)90110-6 · DOI
- Zhou, 2010, Targeting fibrosis in Duchenne muscular dystrophy, J Neuropathol Exp Neurol, 69, 771, 10.1097/NEN.0b013e3181e9a34b · DOI · Paper page
- Mitrpant, 2009, Personalised genetic intervention for Duchenne muscular dystrophy: antisense oligomers and exon skipping, Curr Mol Pharmacol, 2, 110, 10.2174/1874467210902010110 · DOI
- Nelson, 2009, Emerging genetic therapies to treat Duchenne muscular dystrophy, Current Opin Neurol, 22, 532, 10.1097/WCO.0b013e32832fd487 · DOI
- Muir, 2009, Emerging strategies for cell and gene therapy of the muscular dystrophies, Expert Rev Mol Med, 11, e18, 10.1017/S1462399409001100 · DOI · Paper page
- Peault, 2007, Stem and progenitor cells in skeletal muscle development, maintenance, and therapy, Mol Ther, 15, 867, 10.1038/mt.sj.6300145 · DOI · Paper page
- Cossu, 2007, New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials, Trends Mol Med, 13, 520, 10.1016/j.molmed.2007.10.003 · DOI · Paper page
- McGeachie, 1993, Age-related changes in replication of myogenic cells in mdx mice: quantitative autoradiographic studies, J Neurol Sci, 119, 169, 10.1016/0022-510X(93)90130-Q · DOI · Paper page
- Pastoret, 1995, mdx mice show progressive weakness and muscle deterioration with age, J Neurol Sci, 129, 97, 10.1016/0022-510X(94)00276-T · DOI · Paper page
- Lefaucheur, 1995, Phenotype of dystrophinopathy in old mdx mice, Anat Rec, 242, 70, 10.1002/ar.1092420109 · DOI · Paper page
- Stedman, 1991, The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy, Nature, 352, 536, 10.1038/352536a0 · DOI · Paper page
- Chamberlain, 2007, Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma, FASEB J, 21, 10.1096/fj.06-7353com · DOI · Paper page
- Carnwath, 1987, Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles, J Neurol Sci, 80, 39, 10.1016/0022-510X(87)90219-X · DOI · Paper page
- Tanabe, 1986, Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse, Acta Neuropathol (Berl), 69, 91, 10.1007/BF00687043 · DOI · Paper page
- Torres, 1987, The mutant mdx: inherited myopathy in the mouse, Brain, 110, 269, 10.1093/brain/110.2.269 · DOI · Paper page
- Dangain, 1984, Muscle development in mdx mutant mice, Muscle Nerve, 7, 700, 10.1002/mus.880070903 · DOI · Paper page
- Muntoni, 1993, Muscular weakness in the mdx mouse, J Neurol Sci, 120, 71, 10.1016/0022-510X(93)90027-V · DOI
- Grounds, 2008, Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy, Neurobiol Dis, 31, 1, 10.1016/j.nbd.2008.03.008 · DOI · Paper page
- Spurney, 2009, Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures, Muscle Nerve, 39, 591, 10.1002/mus.21211 · DOI · Paper page
- Chapman, 1989, Recovery of Induced Mutations for X Chromosome-Linked Muscular Dystrophy in Mice, Proc Natl Acad Sci U S A, 86, 1292, 10.1073/pnas.86.4.1292 · DOI · Paper page
- Araki, 1997, Targeted disruption of exon 52 in the mouse dystrophin gene induced muscle degeneration similar to that observed in Duchenne muscular dystrophy, Biochem Biophys Res Commun, 238, 492, 10.1006/bbrc.1997.7328 · DOI · Paper page
- Fukada, 2010, Genetic background affects properties of satellite cells and mdx phenotypes, Am J Pathol, 176, 2414, 10.2353/ajpath.2010.090887 · DOI · Paper page
- Im, 1996, Differential expression of dystrophin isoforms in strains of mdx mice with different mutations, Hum Mol Genet, 5, 1149, 10.1093/hmg/5.8.1149 · DOI · Paper page
- Danko, 1992, The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy, Pediatr Res, 32, 128, 10.1203/00006450-199207000-00025 · DOI · Paper page
- Haslett, 2005, The influence of muscle type and dystrophin deficiency on murine expression profiles, Mamm Genome, 16, 739, 10.1007/s00335-005-0053-8 · DOI
- Payne, 2006, Nutritional therapy improves function and complements corticosteroid intervention in mdx mice, Muscle Nerve, 33, 66, 10.1002/mus.20436 · DOI · Paper page
- Kobayashi, 2008, Sarcolemma-localized nNOS is required to maintain activity after mild exercise, Nature, 456, 511, 10.1038/nature07414 · DOI · Paper page
- Carter, 1999, Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation, J Neurosci, 19, 3248, 10.1523/JNEUROSCI.19-08-03248.1999 · DOI · Paper page
- Hamer, 2002, Evans Blue Dye as an in vivo marker of myofibre damage: optimising parameters for detecting initial myofibre membrane permeability, J Anat, 200, 69, 10.1046/j.0021-8782.2001.00008.x · DOI · Paper page
- Heydemann, 2009, Latent TGF-beta-binding protein 4 modifies muscular dystrophy in mice, J Clin Invest, 119, 3703, 10.1172/JCI39845 · DOI · Paper page
- Zhou, 2008, Haploinsufficiency of utrophin gene worsens skeletal muscle inflammation and fibrosis in mdx mice, J Neurol Sci, 264, 106, 10.1016/j.jns.2007.08.029 · DOI
- Huang, 2009, Imatinib attenuates skeletal muscle dystrophy in mdx mice, FASEB J, 23, 2539, 10.1096/fj.09-129833 · DOI · Paper page
- Reddy, 1996, A simplified method for the analysis of hydroxyproline in biological tissues, Clin Biochem, 29, 225, 10.1016/0009-9120(96)00003-6 · DOI · Paper page
- Acharyya, 2007, Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy, J Clin Invest, 117, 889, 10.1172/JCI30556 · DOI · Paper page
- Chandrasekharan, 2010, A human-specific deletion in mouse Cmah increases disease severity in the mdx model of Duchenne muscular dystrophy, Sci Transl Med, 2, 10.1126/scitranslmed.3000692 · DOI · Paper page
- Peterson, 2011, Peptide-based inhibition of NF-kappaB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy, Mol Med, 17, 508, 10.2119/molmed.2010.00263 · DOI
- Rucker, 2004, Rescue of enzyme deficiency in embryonic diaphragm in a mouse model of metabolic myopathy: pompe disease, Development, 131, 3007, 10.1242/dev.01169 · DOI
- Diaz, 1994, Effects of N-acetylcysteine on in vitro diaphragm function are temperature dependent, J Appl Physiol, 77, 2434, 10.1152/jappl.1994.77.5.2434 · DOI · Paper page
- Prezant, 1990, Temperature dependence of rat diaphragm muscle contractility and fatigue, J Appl Physiol, 69, 1740, 10.1152/jappl.1990.69.5.1740 · doi:10.1152/jappl.1990.69.5.1740
- Rodino-Klapac, 2007, A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy, J Transl Med, 5, 45, 10.1186/1479-5876-5-45 · DOI · Paper page
- Martin, 2009, Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild type mice, Am J Physiol Cell Physiol, 296, C476, 10.1152/ajpcell.00456.2008 · DOI · Paper page
- Rabinowitz, 2002, Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity, J Virol, 76, 791, 10.1128/JVI.76.2.791-801.2002 · DOI · Paper page
- Hauser, 1997, Improved adenoviral vectors for gene therapy of Duchenne muscular dystrophy, Neuromuscul Disord, 7, 277, 10.1016/S0960-8966(97)00052-7 · DOI
- Cohn, 2007, Myostatin does not regulate cardiac hypertrophy or fibrosis, Neuromuscul Disord, 17, 290, 10.1016/j.nmd.2007.01.011 · DOI
- Hayes, 1998, Contractile function and low-intensity exercise effects of old dystrophic (mdx) mice, Am J Physiol, 274, C1138, 10.1152/ajpcell.1998.274.4.C1138 · DOI
- Hooper, 1978, Bone length and muscle weight in mice subjected to genetic selection for the relative length of the tibia and radius, Life Sci, 22, 283, 10.1016/0024-3205(78)90529-5 · doi:10.1016/0024-3205(78)90529-5
- Golumbek, 2007, Strength and corticosteroid responsiveness of mdx mice is unchanged by RAG2 gene knockout, Neuromuscul Disord, 17, 376, 10.1016/j.nmd.2007.02.005 · doi:10.1016/j.nmd.2007.02.005
- Wang, 2009, Systemic human minidystrophin gene transfer improves functions and life span of dystrophin and dystrophin/utrophin-deficient mice, J Orthop Res, 27, 421, 10.1002/jor.20781 · DOI · Paper page
- Zeman, 2000, Clenbuterol reduces degeneration of exercised or aged dystrophic (mdx) muscle, Muscle Nerve, 23, 521, 10.1002/(SICI)1097-4598(200004)23:4<521::AID-MUS10>3.0.CO;2-8 · DOI
- Wooddell, 2010, Use of Evans blue dye to compare limb muscles in exercised young and old mdx mice, Muscle Nerve, 41, 487, 10.1002/mus.21527 · DOI
- Yoshimura, 2004, AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype, Mol Ther, 10, 821, 10.1016/j.ymthe.2004.07.025 · DOI · Paper page
- Rodino-Klapac, 2010, Persistent expression of FLAG-tagged micro dystrophin in nonhuman primates following intramuscular and vascular delivery, Mol Ther, 18, 109, 10.1038/mt.2009.254 · DOI · Paper page
- Harper, 2002, Modular flexibility of dystrophin: implications for gene therapy of Duchenne muscular dystrophy, Nat Med, 8, 253, 10.1038/nm0302-253 · DOI · Paper page
- Wang, 2005, Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart, Nature Biotechnol, 23, 321, 10.1038/nbt1073 · DOI · Paper page
- Lai, 2009, Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy, J Clin Invest, 119, 624, 10.1172/JCI36612 · DOI · Paper page
- McClive, 1994, C57BL/6 and C57BL/10 inbred mouse strains differ at multiple loci on chromosome 4, Immunogenetics, 39, 286, 10.1007/BF00188793 · doi:10.1007/bf00188793
- Slingsby, 1996, New microsatellite polymorphisms identified between C57BL/6, Immunogenetics, 43, 72
- Deacon, 2007, A comparison of the behavior of C57BL/6 and C57BL/10 mice, Behav Brain Res, 179, 239, 10.1016/j.bbr.2007.02.009 · DOI
- Lewis, 2005, Inbred mouse strain survey of sucrose intake, Physiol Behav, 85, 546, 10.1016/j.physbeh.2005.06.003 · DOI
- Rafael, 2000, Testing of SHIRPA, a mouse phenotypic assessment protocol, on Dmd(mdx) and Dmd(mdx3cv) dystrophin-deficient mice, Mamm Genome, 11, 725, 10.1007/s003350010149 · DOI
- Barton, 2006, Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle, Am J Physiol Cell Physiol, 290, C411, 10.1152/ajpcell.00192.2005 · DOI · Paper page
- Pegoraro, 2011, SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy, Neurology, 76, 219, 10.1212/WNL.0b013e318207afeb · DOI · Paper page
Cited by
Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy
McGreevy, J. W., Hakim, C. H., McIntosh, M. A., & Duan, D. (2015) · Disease Models & Mechanisms · doi:10.1242/dmm.018424 · Cited by 512
AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models
Sondergaard, P. C., Griffin, D. A., Pozsgai, E. R., Johnson, R. W., Grose, W. E., Heller, K. N., Shontz, K. M., Montgomery, C. L., Liu, J., Clark, K. R., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.172 · Cited by 99
“Mice were euthanized and the diaphragm was dissected with rib attachments and central tendon intact, and placed in K-H buffer at 37°C as previously described.(42,43) A 1–2 mm wide section (length from rib to tendon) of diaphragm was isolated and attached to a force transducer.”
MethodSelf-citationGrose, W. E., Clark, K. R., Griffin, D., Malik, V., Shontz, K. M., Montgomery, C. L., Lewis, S., Brown, R. H., Janssen, P. M. L., Mendell, J. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039233 · Cited by 76
Self-citationPozsgai, E. R., Griffin, D. A., Heller, K. N., Mendell, J. R., & Rodino-Klapac, L. R. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.02.013 · Cited by 76
Self-citationUnderstanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Beastrom, N., Lu, H., Macke, A., Canan, B. D., Johnson, E. K., Penton, C. M., Kaspar, B. K., Rodino-Klapac, L. R., Zhou, L., Janssen, P. M. L., & Montanaro, F.
- Venue
- The American Journal of Pathology
- Publisher
- Elsevier BV
- Published
- 2011-11
- Volume
- 179
- Issue
- 5
- Pages
- 2464-2474
- ISSN
- 0002-9440
- Cited by
- 69
- References
- 5
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 2964 d)
- Funders
- National Institutes of Health (K02 HL083957)
- American Heart Association
- Research Institute, Nationwide Children's Hospital
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.